Literature DB >> 32471669

Contrast Media-Different Types of Contrast Media, Their History, Chemical Properties, and Relative Nephrotoxicity.

Sadichhya Lohani1, Michael R Rudnick2.   

Abstract

History of contrast dates back to the 1890s, with the invention of the radiograph. Nephrotoxicity has been a main limitation in ideal contrast media (CM). High-osmolar contrast media no longer are in clinical use due to overwhelming evidence supporting greater nephrotoxicity with these CM compared with current CM. Contrast-induced nephropathy (CIN) remains a common cause of in-hospital acute kidney injury. The choice contrast agent is determined mainly by cost and institution practice. This review focuses on the history, chemical properties, and experimental and clinical studies on the various groups of CM and their role in CIN.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast media; Contrast-induced acute kidney injury; Contrast-induced nephropathy; High osmolar; Iso-osmolar; Low osmolar

Mesh:

Substances:

Year:  2020        PMID: 32471669     DOI: 10.1016/j.iccl.2020.02.008

Source DB:  PubMed          Journal:  Interv Cardiol Clin        ISSN: 2211-7458


  3 in total

Review 1.  Radiological Screening Methods in Deceased Organ Donation: An Overview of Guidelines Worldwide.

Authors:  K A Chotkan; J W Mensink; R A Pol; N P Van Der Kaaij; L F M Beenen; W N Nijboer; B Schaefer; I P J Alwayn; A E Braat
Journal:  Transpl Int       Date:  2022-05-19       Impact factor: 3.842

2.  A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium.

Authors:  Jiajia Wu; Jianxiao Shen; Wanpeng Wang; Na Jiang; Haijiao Jin; Xiajing Che; Zhaohui Ni; Yan Fang; Shan Mou
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

3.  Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPARγ/NLRP3 Signaling Pathway.

Authors:  Jiayi Wu; Jinhua Huang; En Chen; Xingchun Zheng
Journal:  Dis Markers       Date:  2022-10-03       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.